Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts Japan Advances Rare Earths Ambitions with World’s First Seabed Trial February 4, 2026 Can You Invest in Neuralink? February 4, 2026 Westport Announces $6.5 Million Milestone Payment From Light-Duty Divestiture February 4, 2026